Brain metastases pose a significant challenge in oncology, contributing to morbidity and mortality rates.
These metastases originates from primary tumors in the breast, lung, and melanoma tumors and has promoted the exploration of several treatment modalities, including stereotactic radiosurgery (SRS).
SRS is considered to be one of the most effective treatments for brain metastases due to its precision in delivering high doses of radiation with low damage to the surrounding tissues.
